PubMed Health⌕ Search

Biomedical subjects

L Meiss

Publications and source records attributed to L Meiss.

27 records · Page 2Linked to original sources
PubMed1981

[A device for the preparation of crushed cortical bone (author's transl)].

The advantage of autologous cancellous bone grafts in sites of weak osteogenic potency has long been appreciated. It now needs to be tested whether crushed cortical bone can be used for bone induction in sites of strong osteogenic potency. The grinding device described here enables the preparation of bone dust of variable particle size under sterile conditions.

Animals↗
PubMed1980

[Technique and technical blunders in grafting of large skin defects on extremities and joints with mesh-graft-II-dermatoma after Tanner-Vanderput (author's transl)].

The indication and surgical procedure of mesh skin grafting with mesh graft dermatoma II after Tanner-Vanderput concerning avoidable failures are shown. In order to avoid therapeutic complications of skin grafting in extremities it is of great importance to have a well granulating transplantation ground and to spread out the mesh graft equally. Even in regions of joints good results can be achieved.

Extremities↗
PubMedDate not supplied

[Treatment of chronic plantar fasciitis with botulinum toxin A--an open pilot study on 25 patients with a 14-week-follow-up].

AIM: The conservative and operative treatments of plantar fasciitis tend to be tedious. Unsatisfactory results are common in chronic cases. This study was performed in order to test the hypothesis that the analgesic and anti-inflammatory effect of a single injection of Botulinum toxin A (BoNT A) induces a significant reduction of symptoms. METHOD: 25 patients were included and followed-up for 14 weeks. Prior to injection, all of them had undergone at least two trials of conservative treatment. To determine the optimal treatment dose, 6 patients were injected subfascially with 100 units BoNT A (Dysport), another 6 with 200 units BoNT A. As result of this pre-trial, another 13 patients were treated with the higher dose. The patients documented maximum pain and continuous pain on a visual analogue scale. The strength of the lower leg and foot muscles was clinically assessed. RESULTS: A significant reduction of maximum and continuous pain was seen 2 weeks after injection in the group of 19 patients treated with 200 units BoNT A and persisted until the end of the follow-up. Adverse effects such as weakness of the muscles or systemic reactions have not been observed. CONCLUSION: This pilot study shows the efficacy of a single application of 200 units BoNT A as a treatment option for chronic plantar fasciitis.

Aged↗